This document describes the development of several in vivo experimental models for anti-cancer research including: 1) heterotransplant models using human tumor xenografts in mice to preserve the tumor microenvironment; 2) transgenic mouse models that overexpress oncogenes or knockout tumor suppressor genes; and 3) conditional knockout mouse models where genes can be conditionally deleted in specific tissues. Details are provided on generating transgenic mouse lines that overexpress a deleted form of DNMT3B and generating a conditional HuR knockout mouse line using a targeting vector with loxP sites. The goals are to have repeatable, systematic preclinical models to better evaluate drug efficacy.